Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 165

1.

MARCH8 Ubiquitinates the Hepatitis C Virus Nonstructural 2 Protein and Mediates Viral Envelopment.

Kumar S, Barouch-Bentov R, Xiao F, Schor S, Pu S, Biquand E, Lu A, Lindenbach BD, Jacob Y, Demeret C, Einav S.

Cell Rep. 2019 Feb 12;26(7):1800-1814.e5. doi: 10.1016/j.celrep.2019.01.075.

2.

Temporal trends of co-diagnosis of depression and/or anxiety among female maternal and non-maternal hospitalizations: Results from Nationwide Inpatient Sample 2004-2013.

Pino EC, Zuo Y, Schor SH, Zatwarnicki S, Henderson DC, Borba CP, Milanovic SM, Kalesan B.

Psychiatry Res. 2019 Feb;272:42-50. doi: 10.1016/j.psychres.2018.12.077. Epub 2018 Dec 15.

PMID:
30579180
3.

Viral journeys on the intracellular highways.

Robinson M, Schor S, Barouch-Bentov R, Einav S.

Cell Mol Life Sci. 2018 Oct;75(20):3693-3714. doi: 10.1007/s00018-018-2882-0. Epub 2018 Jul 24. Review.

4.

Optimization of Isothiazolo[4,3- b]pyridine-Based Inhibitors of Cyclin G Associated Kinase (GAK) with Broad-Spectrum Antiviral Activity.

Pu SY, Wouters R, Schor S, Rozenski J, Barouch-Bentov R, Prugar LI, O'Brien CM, Brannan JM, Dye JM, Herdewijn P, De Jonghe S, Einav S.

J Med Chem. 2018 Jul 26;61(14):6178-6192. doi: 10.1021/acs.jmedchem.8b00613. Epub 2018 Jul 16.

5.

Feasibility and biological rationale of repurposing sunitinib and erlotinib for dengue treatment.

Pu SY, Xiao F, Schor S, Bekerman E, Zanini F, Barouch-Bentov R, Nagamine CM, Einav S.

Antiviral Res. 2018 Jul;155:67-75. doi: 10.1016/j.antiviral.2018.05.001. Epub 2018 May 16.

6.

Interactions between the Hepatitis C Virus Nonstructural 2 Protein and Host Adaptor Proteins 1 and 4 Orchestrate Virus Release.

Xiao F, Wang S, Barouch-Bentov R, Neveu G, Pu S, Beer M, Schor S, Kumar S, Nicolaescu V, Lindenbach BD, Randall G, Einav S.

MBio. 2018 Mar 13;9(2). pii: e02233-17. doi: 10.1128/mBio.02233-17.

7.

Erratum for Barouch-Bentov et al., "Hepatitis C Virus Proteins Interact with the Endosomal Sorting Complex Required for Transport (ESCRT) Machinery via Ubiquitination To Facilitate Viral Envelopment".

Barouch-Bentov R, Neveu G, Xiao F, Beer M, Bekerman E, Schor S, Campbell J, Boonyaratanakornkit J, Lindenbach B, Lu A, Jacob Y, Einav S.

MBio. 2018 Jan 9;9(1). pii: e02234-17. doi: 10.1128/mBio.02234-17. No abstract available.

8.

Combating Intracellular Pathogens with Repurposed Host-Targeted Drugs.

Schor S, Einav S.

ACS Infect Dis. 2018 Feb 9;4(2):88-92. doi: 10.1021/acsinfecdis.7b00268. Epub 2018 Jan 3.

9.

Repurposing of Kinase Inhibitors as Broad-Spectrum Antiviral Drugs.

Schor S, Einav S.

DNA Cell Biol. 2018 Feb;37(2):63-69. doi: 10.1089/dna.2017.4033. Epub 2017 Nov 17. Review.

10.

Mobile Health Apps in OB-GYN-Embedded Psychiatric Care: Commentary.

Mehralizade A, Schor S, Coleman CM, Oppenheim CE, Denckla CA, Borba CP, Henderson DC, Wolff J, Crane S, Nettles-Gomez P, Pal A, Milanovic S.

JMIR Mhealth Uhealth. 2017 Oct 6;5(10):e152. doi: 10.2196/mhealth.7988.

11.

Hepatitis C Virus Proteins Interact with the Endosomal Sorting Complex Required for Transport (ESCRT) Machinery via Ubiquitination To Facilitate Viral Envelopment.

Barouch-Bentov R, Neveu G, Xiao F, Beer M, Bekerman E, Schor S, Campbell J, Boonyaratanakornkit J, Lindenbach B, Lu A, Jacob Y, Einav S.

MBio. 2016 Nov 1;7(6). pii: e01456-16. doi: 10.1128/mBio.01456-16. Erratum in: MBio. 2018 Jan 9;9(1):.

12.

Biological activity differences between TGF-β1 and TGF-β3 correlate with differences in the rigidity and arrangement of their component monomers.

Huang T, Schor SL, Hinck AP.

Biochemistry. 2014 Sep 16;53(36):5737-49. doi: 10.1021/bi500647d. Epub 2014 Sep 5.

13.

Directed evolution of Gloeobacter violaceus rhodopsin spectral properties.

Engqvist MK, McIsaac RS, Dollinger P, Flytzanis NC, Abrams M, Schor S, Arnold FH.

J Mol Biol. 2015 Jan 16;427(1):205-20. doi: 10.1016/j.jmb.2014.06.015. Epub 2014 Jun 28.

PMID:
24979679
14.

Biomaterials in regenerative medicine: engineering to recapitulate the natural.

Keatch RP, Schor AM, Vorstius JB, Schor SL.

Curr Opin Biotechnol. 2012 Aug;23(4):579-82. doi: 10.1016/j.copbio.2012.01.017. Epub 2012 Mar 14. Review.

PMID:
22421635
15.

Bistable switch in migration stimulating factor expression: regulation by the concerted signalling of transforming growth factor-β1 and the extracellular matrix.

Schor SL, Ellis IR, Jones SJ, Woolston AM, Schor AM.

Int J Cancer. 2012 May 1;130(9):2024-32. doi: 10.1002/ijc.26213. Epub 2011 Aug 16.

16.

Migration-stimulating factor as a novel biomarker in salivary gland tumours.

Aljorani LE, Bankfalvi A, Carey FA, Harada K, Ohe G, Jones SJ, Ellis IR, Schor SL, Schor AM.

J Oral Pathol Med. 2011 Nov;40(10):747-54. doi: 10.1111/j.1600-0714.2011.01044.x. Epub 2011 Apr 11.

PMID:
21481007
17.

Identification, in vitro activity and mode of action of phosphoinositide-dependent-1 kinase inhibitors as antifungal molecules.

Baxter BK, DiDone L, Ogu D, Schor S, Krysan DJ.

ACS Chem Biol. 2011 May 20;6(5):502-10. doi: 10.1021/cb100399x. Epub 2011 Feb 22.

18.

Migration Stimulating Factor (MSF) promotes fibroblast migration by inhibiting AKT.

Ellis IR, Jones SJ, Lindsay Y, Ohe G, Schor AM, Schor SL, Leslie NR.

Cell Signal. 2010 Nov;22(11):1655-9. doi: 10.1016/j.cellsig.2010.06.005. Epub 2010 Jul 1.

PMID:
20600851
19.

Multi-factorial modulation of IGD motogenic potential in MSF (migration stimulating factor).

Ellis IR, Jones SJ, Staunton D, Vakonakis I, Norman DG, Potts JR, Milner CM, Meenan NA, Raibaud S, Ohea G, Schor AM, Schor SL.

Exp Cell Res. 2010 Sep 10;316(15):2465-76. doi: 10.1016/j.yexcr.2010.04.003. Epub 2010 Apr 18.

PMID:
20403349
20.

Angiogenesis and tumour progression: migration-stimulating factor as a novel target for clinical intervention.

Schor AM, Schor SL.

Eye (Lond). 2010 Mar;24(3):450-8. doi: 10.1038/eye.2009.314. Epub 2009 Dec 18. Review.

PMID:
20019766
21.

Motogenic sites in human fibronectin are masked by long range interactions.

Vakonakis I, Staunton D, Ellis IR, Sarkies P, Flanagan A, Schor AM, Schor SL, Campbell ID.

J Biol Chem. 2009 Jun 5;284(23):15668-75. doi: 10.1074/jbc.M109.003673. Epub 2009 Apr 14.

22.

Assessment of vascularity as an index of angiogenesis in periradicular granulomas. Comparison with oral carcinomas and normal tissue counterparts.

Davey KJ, Perrier S, Ohe G, Gilbert AD, Bankfalvi A, Saunders WP, Schor SL, Schor AM.

Int Endod J. 2008 Nov;41(11):987-96. doi: 10.1111/j.1365-2591.2008.01466.x.

PMID:
19133088
23.

Differential involvement of TGF-beta1 in mediating the motogenic effects of TSP-1 on endothelial cells, fibroblasts and oral tumour cells.

Motegi K, Harada K, Ohe G, Jones SJ, Ellis IR, Crouch DH, Schor SL, Schor AM.

Exp Cell Res. 2008 Aug 1;314(13):2323-33. doi: 10.1016/j.yexcr.2008.04.013. Epub 2008 May 9.

PMID:
18555217
24.

Co-expression by keratinocytes of migration stimulating factor (MSF) and a functional inhibitor of its bioactivity (MSFI).

Jones SJ, Florence MM, Ellis IR, Kankova K, Schor SL, Schor AM.

Exp Cell Res. 2007 Dec 10;313(20):4145-57. Epub 2007 Sep 21.

PMID:
17949711
25.

The role of the fibronectin IGD motif in stimulating fibroblast migration.

Millard CJ, Ellis IR, Pickford AR, Schor AM, Schor SL, Campbell ID.

J Biol Chem. 2007 Dec 7;282(49):35530-5. Epub 2007 Oct 5.

26.

EGF AND TGF-alpha motogenic activities are mediated by the EGF receptor via distinct matrix-dependent mechanisms.

Ellis IR, Schor AM, Schor SL.

Exp Cell Res. 2007 Feb 15;313(4):732-41. Epub 2006 Dec 5.

PMID:
17196962
27.

Synthesis of an IGD peptidomimetic with motogenic activity.

Shpiro N, Ellis IR, Dines TJ, Schor AM, Schor SL, Norman DG, Marquez R.

Mol Biosyst. 2005 Oct;1(4):318-20. Epub 2005 Aug 26.

PMID:
16880997
28.

A novel 'sandwich' assay for quantifying chemo-regulated cell migration within 3-dimensional matrices: wound healing cytokines exhibit distinct motogenic activities compared to the transmembrane assay.

Schor SL, Ellis IR, Harada K, Motegi K, Anderson AR, Chaplain MA, Keatch RP, Schor AM.

Cell Motil Cytoskeleton. 2006 May;63(5):287-300.

PMID:
16528704
29.
30.

Extraction of RNA from archival tissues and measurement of thrombospondin-1 mRNA in normal, dysplastic, and malignant oral tissues.

Macluskey M, Baillie R, Morrow H, Schor SL, Schor AM.

Br J Oral Maxillofac Surg. 2006 Apr;44(2):116-23.

PMID:
15908066
31.

Migration-stimulating factor: a genetically truncated onco-fetal fibronectin isoform expressed by carcinoma and tumor-associated stromal cells.

Schor SL, Ellis IR, Jones SJ, Baillie R, Seneviratne K, Clausen J, Motegi K, Vojtesek B, Kankova K, Furrie E, Sales MJ, Schor AM, Kay RA.

Cancer Res. 2003 Dec 15;63(24):8827-36.

32.

Growth factors in the treatment of diabetic foot ulcers.

Bennett SP, Griffiths GD, Schor AM, Leese GP, Schor SL.

Br J Surg. 2003 Feb;90(2):133-46. Review.

PMID:
12555288
33.

Microengineering as a tool to study substratum modulation and cell behaviour.

Keatch RP, Armoogum K, Schor SL, Pridham MS, Banks K, Khor TY, Matthew C.

Biomed Tech (Berl). 2002;47 Suppl 1 Pt 1:386-9.

PMID:
12451872
34.

Phenotypic and genetic alterations in mammary stroma: implications for tumour progression.

Schor SL, Schor AM.

Breast Cancer Res. 2001;3(6):373-9. Epub 2001 Sep 6. Review.

35.

Expression of vascular endothelial growth factor in normal and tumour oral tissues assessed with different antibodies.

Baillie R, Harada K, Carlile J, Macluskey M, Schor SL, Schor AM.

Histochem J. 2001 May;33(5):287-94.

PMID:
11563542
36.

Vascular endothelial growth factor (VEGF) expression in oral tissues: possible relevance to angiogenesis, tumour progression and field cancerisation.

Carlile J, Harada K, Baillie R, Macluskey M, Chisholm DM, Ogden GR, Schor SL, Schor AM.

J Oral Pathol Med. 2001 Sep;30(8):449-57.

PMID:
11545235
37.

Chemotaxis and Chemokinesis in 3D Macromolecular Matrices : Relevance to Angiogenesis.

Schor AM, Ellis I, Schor SL.

Methods Mol Med. 2001;46:163-83. doi: 10.1385/1-59259-143-4:163.

PMID:
21340919
38.

Collagen gel assay for angiogenesis : induction of endothelial cell sprouting.

Schor AM, Ellis I, Schor SL.

Methods Mol Med. 2001;46:145-62. doi: 10.1385/1-59259-143-4:145.

PMID:
21340918
39.

Apoptosis, proliferation, and angiogenesis in oral tissues. Possible relevance to tumour progression.

Macluskey M, Chandrachud LM, Pazouki S, Green M, Chisholm DM, Ogden GR, Schor SL, Schor AM.

J Pathol. 2000 Aug;191(4):368-75.

PMID:
10918211
41.

Functional magnetic resonance imaging in real time (FIRE): sliding-window correlation analysis and reference-vector optimization.

Gembris D, Taylor JG, Schor S, Frings W, Suter D, Posse S.

Magn Reson Med. 2000 Feb;43(2):259-68.

42.

The association between epithelial proliferation and disease progression in the oral mucosa.

Macluskey M, Ogden GR, Green M, Chisholm DM, Schor SL, Schor AM.

Oral Oncol. 1999 Jul;35(4):409-14.

PMID:
10645407
43.

Motogenic activity of IGD-containing synthetic peptides.

Schor SL, Ellis I, Banyard J, Schor AM.

J Cell Sci. 1999 Nov;112 ( Pt 22):3879-88.

44.

Regulation of fibroblast-induced collagen gel contraction by interleukin-1beta.

Irwin CR, Myrillas T, Smyth M, Doogan J, Rice C, Schor SL.

J Oral Pathol Med. 1998 Jul;27(6):255-9.

PMID:
9707277
45.
46.

The association between tumour progression and vascularity in the oral mucosa.

Pazouki S, Chisholm DM, Adi MM, Carmichael G, Farquharson M, Ogden GR, Schor SL, Schor AM.

J Pathol. 1997 Sep;183(1):39-43.

PMID:
9370945
47.
49.

Substratum-dependent stimulation of fibroblast migration by the gelatin-binding domain of fibronectin.

Schor SL, Ellis I, Dolman C, Banyard J, Humphries MJ, Mosher DF, Grey AM, Mould AP, Sottile J, Schor AM.

J Cell Sci. 1996 Oct;109 ( Pt 10):2581-90.

50.

Subpopulations of fetal-like gingival fibroblasts: characterisation and potential significance for wound healing and the progression of periodontal disease.

Schor SL, Ellis I, Irwin CR, Banyard J, Seneviratne K, Dolman C, Gilbert AD, Chisholm DM.

Oral Dis. 1996 Jun;2(2):155-66. Review.

PMID:
8957929

Supplemental Content

Support Center